Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Victoria replaces CFO with investment banking vet

(Sharecast News) - Flooring products manufacturer Victoria has announced that chief financial officer Brian Morgan is to leave the company after three years of service, causing shares to rise strongly on Monday. Morgan, who is set to step down in late-June, has "decided to seek a role outside Victoria" now that the negotiated refinancing of its debt is now well advanced, the company said.

Victoria has appointed Alec Pratt, a senior finance leader with 16 years' experience in investment banking, as Morgan's replacement.

Pratt joins from Deutsche Bank, where he was most recently co-head of EMEA Financial Sponsor M&A, and previously worked at Numis and JPMorgan.

The stock was trading 6.4% higher at 93.39p by 0832 GMT.

"Alec adds to the strong bench of management talent carefully built at Victoria over the last 12 years," said chair Geoff Wilding.

"He is uniquely qualified to take on this role and his considerable finance and capital markets experience will be extremely beneficial for Victoria's continued growth and we look forward to updating shareholders on our progress."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.